Hsieh Ming-Jer, Lee Cheng-Hung, Chen Chun-Chi, Chang Shang-Hung, Wang Chao-Yung, Hsieh I-Chang
Department of Cardiology, Percutaneous Coronary Intervention Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Department of Cardiology, Percutaneous Coronary Intervention Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
J Cardiol. 2017 Jan;69(1):136-143. doi: 10.1016/j.jjcc.2016.02.005. Epub 2016 Mar 4.
Predictive value of the Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs or alcohol use (HAS-BLED) score for clinical outcomes has been investigated in patients with and without atrial fibrillation. Many factors in the HAS-BLED model have been reported to be prognostic predictors in patients with post-myocardial infarction (MI). However, few studies have investigated the predictive value of HAS-BLED score on long-term survival in patients with post-MI.
A total of 617 patients with non-ST elevation MI (NSTEMI) without atrial fibrillation were enrolled. The Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), Can Rapid Risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE), and HAS-BLED risk scores were calculated for each patient.
The C-statistics of TIMI, GRACE, CRUSADE, and HAS-BLED scores for 3-year survival were 0.658, 0.749, 0.756, and 0.765, respectively. For 3-year survival prediction, GRACE, CRUSADE, and HAS-BLED scores, respectively demonstrated superior performance than TIMI score and there was no significant difference between these three scores (GRACE vs. TIMI: z=1.615, p=0.027; CRUSADE vs. TIMI: z=1.371, p=0.043; HAS-BLED vs. TIMI: z=1.899, p=0.014; CRUSADE vs. GRACE: z=0.078, p=0.234; HAS-BLED vs. GRACE: z=0.435, p=0.166; HAS-BLED vs. CRUSADE: z=0.353, p=0.181). Multivariate analysis showed left ventricular ejection fraction <40%, old age, stroke history, bleeding history, and abnormal renal and liver function were independent predictors for 3-year mortality.
HAS-BLED scoring system is similar to the GRACE and CRUSADE systems but better than TIMI system to predict long-term survival outcomes in patients with NSTEMI without atrial fibrillation. However, HAS-BLED score is easier to calculate than GRACE and CRUSADE scores.
高血压、肾/肝功能异常、中风、出血史或易发性、国际标准化比值不稳定、老年、药物或酒精使用(HAS - BLED)评分对有或无房颤患者临床结局的预测价值已得到研究。HAS - BLED模型中的许多因素已被报道为心肌梗死后(MI)患者的预后预测指标。然而,很少有研究探讨HAS - BLED评分对MI后患者长期生存的预测价值。
共纳入617例无房颤的非ST段抬高型心肌梗死(NSTEMI)患者。计算每位患者的心肌梗死溶栓(TIMI)、急性冠状动脉事件全球注册(GRACE)、不稳定型心绞痛患者快速风险分层能否通过早期实施ACC/AHA指南抑制不良结局(CRUSADE)以及HAS - BLED风险评分。
TIMI、GRACE、CRUSADE和HAS - BLED评分对3年生存率的C统计量分别为0.658、0.749、0.756和0.765。对于3年生存预测,GRACE、CRUSADE和HAS - BLED评分分别显示出比TIMI评分更好的性能,且这三个评分之间无显著差异(GRACE与TIMI:z = 1.615,p = 0.027;CRUSADE与TIMI:z = 1.371,p = 0.043;HAS - BLED与TIMI:z = 1.899,p = 0.014;CRUSADE与GRACE:z = 0.078,p = 0.234;HAS - BLED与GRACE:z = 0.435,p = 0.166;HAS - BLED与CRUSADE:z = 0.353,p = 0.181)。多因素分析显示左心室射血分数<40%、老年、中风史、出血史以及肾和肝功能异常是3年死亡率的独立预测因素。
HAS - BLED评分系统与GRACE和CRUSADE系统相似,但在预测无房颤的NSTEMI患者长期生存结局方面优于TIMI系统。然而,HAS - BLED评分比GRACE和CRUSADE评分更容易计算。